Comparison of low fixed dose versus standard-dose rituximab to treat thrombotic thrombocytopenic purpura in the acute phase and preemptively during remission-Reference-Cited by-同舟云学术

Comparison of low fixed dose versus standard-dose rituximab to treat thrombotic thrombocytopenic purpura in the acute phase and preemptively during remission

Published:2020-12 Issue:6 Volume:59 Page:102885
ISSN:1473-0502
Container-title:Transfusion and Apheresis Science
language:en
Short-container-title:Transfusion and Apheresis Science

Author:

Reddy Manasa S.^ORCID,Hofmann Sandra,Shen Yu Min,Nagalla Srikanth,Rambally Siayareh,Usmani Amena,Sarode Ravi

Publisher

Elsevier BV

Subject

Hematology

Reference16 articles.

1. Thrombotic thrombocytopenic purpura;Joly;Blood,2017

2. Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura;Hie;Blood,2014

3. Rituximab for thrombotic thrombocytopenic purpura: benefit of early administration during acute episodes and use of prophylaxis to prevent relapse;Westwood;J Thromb Haemost,2013

4. Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura;Jestin;Blood,2018

5. Pathophysiology of thrombotic thrombocytopenic purpura;Sadler;Blood,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombotic thrombocytopenic purpura;The Rose and Mackay Textbook of Autoimmune Diseases;2024

2. Predictors of relapse and prophylactic management of immune thrombotic thrombocytopenic purpura;Transfusion and Apheresis Science;2023-08

3. Egészségügyi szakmai irányelv – A thrombotikus thrombocytopeniás purpura (TTP) és a haemolytikus uraemiás syndroma (HUS) kezeléséről;Orvosi Hetilap;2022-09-19

4. Advances in the management of TTP;Blood Reviews;2022-09

5. Predictors of relapse and preventative strategies in immune thrombotic thrombocytopenic purpura;Expert Review of Hematology;2021-11-02